NRSN · NeuroSense Therapeutics Ltd. · Documents
Market Cap
$5.06M
Shares
1.90M
Volume · Oct 20
13.85K
Avg daily vol (26 sessions)
25.85K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 20-F | — | 2024-04-04 | 2023-12-31 | |
| 6-K | — | 2024-02-22 | — | |
| 6-K | — | 2024-02-07 | — | |
| 6-K | — | 2024-01-09 | — | |
| 6-K | — | 2024-01-09 | — | |
| 6-K | — | 2023-12-27 | — | |
| 6-K | — | 2023-12-21 | — | |
| 6-K | — | 2023-12-14 | — | |
| 6-K | — | 2023-12-05 | — | |
| 6-K | — | 2023-11-28 | — | |
| 6-K | — | 2023-11-13 | — | |
| 6-K | — | 2023-11-06 | — | |
| 6-K | — | 2023-10-17 | — | |
| 6-K | — | 2023-10-04 | — | |
| 6-K | — | 2023-10-02 | — | |
| 6-K | — | 2023-09-29 | — | |
| 6-K | — | 2023-09-20 | — | |
| 6-K | — | 2023-09-19 | — | |
| 6-K | — | 2023-09-12 | — | |
| F-1/A | — | 2023-08-31 | — | |
| 6-K | — | 2023-08-16 | 2023-06-30 | |
| F-1/A | — | 2023-08-14 | — | |
| F-1 | — | 2023-07-21 | — | |
| 6-K | — | 2023-07-06 | — | |
| 6-K | — | 2023-06-23 | — | |
| 6-K | — | 2023-06-13 | — | |
| 6-K | — | 2023-06-08 | — | |
| 6-K | — | 2023-06-01 | — | |
| 6-K | — | 2023-05-31 | — | |
| 6-K | — | 2023-05-25 | — | |
| 6-K | — | 2023-05-15 | — | |
| 6-K | — | 2023-05-02 | — | |
| 6-K | — | 2023-05-02 | — | |
| 6-K | — | 2023-04-26 | — | |
| 6-K | — | 2023-04-20 | — | |
| 6-K | — | 2023-04-17 | — | |
| 6-K | — | 2023-04-17 | — | |
| 6-K | — | 2023-04-14 | — | |
| 20-F | — | 2023-03-22 | 2022-12-31 | |
| 6-K | — | 2023-03-20 | — | |
| 6-K | — | 2023-02-13 | — | |
| 6-K | — | 2023-02-09 | — | |
| 6-K | — | 2023-02-08 | — | |
| 6-K | — | 2023-02-06 | — | |
| 6-K | — | 2023-01-19 | — | |
| 6-K/A | — | 2023-01-19 | 2022-06-30 | |
| F-3 | — | 2023-01-19 | — | |
| 6-K | — | 2022-12-15 | — | |
| 6-K | — | 2022-12-01 | — | |
| 6-K | — | 2022-11-29 | — |
Showing 101–150 of 194 filings